Previous reports have shown the potential role of SETD2 inactivation in carcinogenesis and progression [10, 29], and SETD2 is required for regulating the p53-dependent cell-cycle checkpoint and cell survival following DNA damage in ccRCC cells [55]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.